CFO appointment
Quince Therapeutics, Inc. appoints John Militello as CFO
Quince Therapeutics, Inc. reported in a Form 8-K filed July 31, 2026 that John Militello was appointed Chief Financial Officer.
In the filing's words
John Militello, CPA , age 52, was conditionally appointed as the Company’s Chief Financial Officer and will serve as the Company’s Principal Financial Officer and Principal Accounting Officer upon his appointment.
Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.
| Company | Quince Therapeutics, Inc. (QNCX) |
|---|---|
| Event | Appointment |
| Incoming | John Militello |
| Title in the filing | Chief Financial Officer |
| Effective | not stated in the source |
| 8-K filed | July 31, 2026 |
| Internal promotion | Yes |
| Prior role (per filing) | Head of Finance, Orphai Therapeutics, LLC |
| SEC CIK | 0001662774 |
Quince Therapeutics, Inc. reported this change in a Form 8-K, Item 5.02, filed July 31, 2026. The filing's own words are quoted above.
Sources
- sec.gov · SEC filing, Item 5.02 · accessed 2026-09-26
Documented unknowns
- effective: The filing gives "the Effective Time", which is not a calendar date.
Something wrong about John Militello? Send a correction with the primary source.